Home
Headlines & Research Highlights
TRIUMF welcomes McMaster University as newest full member
12 April 2019
Building on nearly 20 years of scientific collaboration, McMaster joins the ranks of full member university partners at TRIUMF.
CDRD and TRIUMF announce collaboration to revolutionize the fight against cancer with targeted alpha therapy
02 April 2019
Speaking at the 11th International Symposium on Targeted Alpha Therapy (TAT 11) in Ottawa, the organizations announced today a new partnership that brings together their respective R&D, manufacturing, and commercialization strengths to develop innovative, personalized cancer treatments.
TRIUMF receives historic investment in 2019 federal budget
19 March 2019
Details of the new funding were included in the 2019 federal budget, which was announced today in Ottawa.
TRIUMF Theory group contributes to the solution of a long-standing beta decay puzzle
11 March 2019
An international collaboration, including several members from TRIUMF’s Theory Department, today published results that may dispel a long-standing mystery surrounding β-decay rates.
Celebrating 40 years of nuclear medicine with TRIUMF’s Applied Technology Group
06 March 2019
As we round the corner on TRIUMF’s 50th birthday, we also look back at one of its most important and enduring relationships and a team who has stewarded a critical contribution to the lab’s growth and success for over four decades.
TRIUMF community celebrates recipients of inaugural Above & Beyond Awards
13 February 2019
The laboratory’s inaugural peer recognition awards highlighted ingenuity, safety, and community-building.
